Getinge completes Paragonix Technologies integration
The combined entity accelerates innovation in transplant care, launching new products and entering new markets.
See the latest news and media coverage for Getinge. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical technology company
getinge.comLast updated
In short: Getinge completed the integration of Paragonix Technologies and achieved record organic growth in early 2026, despite mixed earnings results.
The combined entity accelerates innovation in transplant care, launching new products and entering new markets.
The MOHKI clinic, equipped with Getinge products, has treated over 70 children with congenital heart defects, including pioneering open-heart and TGA surgeries.
A jury found no infringement of Maquet's heart pump patents, with no financial impact.
The updated platform handles up to 24 trays and 600 lbs in the same footprint, increasing output without extra space or infrastructure. Announced at HSPA 2026.
Getinge's CEO Mattias Perjos bought 25,000 shares in the medical technology company on Friday for nearly 4.7 million kronor. The stock rises on the news.
Getinge today announces that a jury in the United States District Court for the District of Massachusetts has delivered a verdict in favor of Abiomed...
Getinge AB () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 30% Off TipRanks. Unlock hedge fund-level...
Getinge (OM:GETI B) plans significant board changes at its 2026 AGM. Shareholders are set to vote on the election of Camilla Sylvest to the board...
Track Getinge and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.